News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Par Pharmaceutical, Inc. Announces Fourth Quarter And Full Year 2013 Conference Call



3/13/2014 11:53:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WOODCLIFF LAKE, N.J., March 13, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Thursday, March 20, 2014 at 10:00 a.m. EDT to review its results of operations for the fourth quarter and full year ended December 31, 2013. Par is privately held and currently makes certain financial information available to the public in its filings with the Securities and Exchange Commission. Par will file its financial statements for the year ended December 31, 2013 with the SEC prior to the call.

Only holders of Par's debt securities, certain prospective holders of Par's debt securities and research analysts who cover or intend to cover Par and its debt securities may participate in the conference call by requesting access to the secured area of Par's website at http://www.parpharm.com/financialinfo for dial-in information.

About Par Pharmaceutical Companies

Par Pharmaceutical Companies, Inc. is a privately-held, U.S.-based specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press release and other company information, visit www.parpharm.com.

SOURCE Par Pharmaceutical Companies, Inc.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES